WHO WE ARE PIPELINE CLINICAL TRIALS MEDICAL PROFESSIONALS PATIENTS & CAREGIVERS INVESTORS & MEDIA PARTNERS
At Ayala, we are focused on developing targeted therapies for people with cancer in whom the Notch pathway is activated.
We target genetically defined, clinically underserved cancers, where we can have the most impact.
Improve treatment outcomes for people living with rare and aggressive cancers
Place people living with cancer at the center of everything we do
Be open, honest, and ethical in all our endeavors—always
Bring innovative products to market in a safe, timely manner
Work with patients, physicians, nurses and support groups to develop meaningful treatment advancements
